Literature DB >> 23224716

Sustained and differential antibody responses to virulence proteins of Brucella melitensis during acute and chronic infections in human brucellosis.

J Xu1, Y Qiu, M Cui, Y Ke, Q Zhen, X Yuan, Y Yu, X Du, J Yuan, H Song, Z Wang, G Gao, S Yu, Y Wang, L Huang, Z Chen.   

Abstract

Brucellosis is an important zoonotic disease caused primarily by the bacterial pathogens Brucella melitensis and B. abortus. The pathogens cause debilitating febrile illness that can progress into a long-lasting disease with severe complications in humans. Understanding the mechanisms by which the host immune system responds to the infection will provide important information on the pathogenesis and development of differential diagnostic assays. In this study, a protein microarray was used to evaluate the antibody responses of brucellosis patients at different infection stages. A total of 107 outer membrane proteins, surface-exposed or secreted proteins, and known or putative virulence-associated proteins of B. melitensis were successfully expressed in Escherichia coli and used to fabricate the protein microarray. Then, 99 serum samples from acute, chronic, primary infection, or relapse brucellosis patients were probed with the protein microarray. Antibodies to 66 of the proteins were detected at least in one serum sample. Among the antigens, the combination of BMEII0318, BMEII0513, BMEI0748, and BMEII1116 could be used as serodiagnostic antigens for brucellosis. Patients at different infection stages show distinct antibody profiles. The numbers of antibodies in the relapse patients were superior to those in the primary infection patients, and the response magnitude of antibodies in the chronic infection patients was higher than those in the acute brucellosis patients. The sustained and differential antibody profiles of patients at different infection stages have implications for the development of new serological methods for the accurate diagnosis of human brucellosis, and contribute to a more detailed understanding of the pathogenesis of chronic brucellosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23224716     DOI: 10.1007/s10096-012-1767-7

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  42 in total

Review 1.  Brucellosis.

Authors:  Georgios Pappas; Nikolaos Akritidis; Mile Bosilkovski; Epameinondas Tsianos
Journal:  N Engl J Med       Date:  2005-06-02       Impact factor: 91.245

2.  Proteomic analysis of Brucella abortus cell envelope and identification of immunogenic candidate proteins for vaccine development.

Authors:  Joseph P Connolly; Diego Comerci; Timothy G Alefantis; Alexander Walz; Marian Quan; Ryan Chafin; Paul Grewal; Cesar V Mujer; Rodolfo A Ugalde; Vito G DelVecchio
Journal:  Proteomics       Date:  2006-07       Impact factor: 3.984

3.  Recombinant OMP28 antigen-based indirect ELISA for serodiagnosis of bovine brucellosis.

Authors:  Pallab Chaudhuri; Rajeev Prasad; Vinoth Kumar; Arunakumar Gangaplara
Journal:  Mol Cell Probes       Date:  2009-12-16       Impact factor: 2.365

4.  The 16MΔvjbR as an ideal live attenuated vaccine candidate for differentiation between Brucella vaccination and infection.

Authors:  Yufei Wang; Yaoxia Bai; Qing Qu; Jie Xu; Yanfen Chen; Zhijun Zhong; Yefeng Qiu; Tongkun Wang; Xinying Du; Zhoujia Wang; Shuang Yu; Simei Fu; Jing Yuan; Qing Zhen; Yaqing Yu; Zeliang Chen; Liuyu Huang
Journal:  Vet Microbiol       Date:  2011-04-04       Impact factor: 3.293

5.  Liposomised recombinant ribosomal L7/L12 protein protects BALB/c mice against Brucella abortus 544 infection.

Authors:  A I Mallick; H Singha; P Chaudhuri; Ahmad Nadeem; Shadab Ahmad Khan; Khurshid Ahmad Dar; M Owais
Journal:  Vaccine       Date:  2007-01-25       Impact factor: 3.641

6.  Endogenous gamma interferon mediates resistance to Brucella abortus infection.

Authors:  Y Zhan; C Cheers
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

7.  Large scale immune profiling of infected humans and goats reveals differential recognition of Brucella melitensis antigens.

Authors:  Li Liang; Diana Leng; Chad Burk; Rie Nakajima-Sasaki; Matthew A Kayala; Vidya L Atluri; Jozelyn Pablo; Berkay Unal; Thomas A Ficht; Eduardo Gotuzzo; Mayuko Saito; W John W Morrow; Xiaowu Liang; Pierre Baldi; Robert H Gilman; Joseph M Vinetz; Renée M Tsolis; Philip L Felgner
Journal:  PLoS Negl Trop Dis       Date:  2010-05-04

8.  Epitope mapping of the Brucella melitensis BP26 immunogenic protein: usefulness for diagnosis of sheep brucellosis.

Authors:  Patricia Seco-Mediavilla; Jean-Michel Verger; Maggy Grayon; Axel Cloeckaert; Clara M Marín; Michel S Zygmunt; Luis Fernández-Lago; Nieves Vizcaíno
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

9.  Chronic brucellosis and persistence of Brucella melitensis DNA.

Authors:  Maria Jesús Castaño; Javier Solera
Journal:  J Clin Microbiol       Date:  2009-05-06       Impact factor: 5.948

10.  Antigen-specific acquired immunity in human brucellosis: implications for diagnosis, prognosis, and vaccine development.

Authors:  Anthony P Cannella; Renee M Tsolis; Li Liang; Philip L Felgner; Mayuko Saito; Alessandro Sette; Eduardo Gotuzzo; Joseph M Vinetz
Journal:  Front Cell Infect Microbiol       Date:  2012-02-01       Impact factor: 5.293

View more
  1 in total

1.  Evaluation of chimeric proteins for serological diagnosis of brucellosis in cattle.

Authors:  Aitbay K Bulashev; Bakytkali K Ingirbay; Kanatbek N Mukantayev; Alfiya S Syzdykova
Journal:  Vet World       Date:  2021-08-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.